Apolipoprotein A-I, cyclodextrins and liposomes as potential drugs for the reversal of atherosclerosis. A review

Journal of Pharmacy and Pharmacology

Volumn 52, Issue 7, 2000, Pages 731-761

  Dass, Crispin R ^a   Jessup, Wendy ^b  

^a JOHNSON AND JOHNSON   (United States)

^b HEART RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

7 OXOCHOLESTEROL; APOLIPOPROTEIN A1; CARBAMAZEPINE; CHOLESTEROL; CYCLODEXTRIN DERIVATIVE; ESTRADIOL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LIPOSOME; OLIGONUCLEOTIDE; OLIGOSACCHARIDE; OXYSTEROL; PHOSPHOLIPID; PHYTOSTEROL; SITOSTEROL; TESTOSTERONE;

ATHEROSCLEROSIS; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CLINICAL TRIAL; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG SAFETY; HUMAN; IN VIVO STUDY; NONHUMAN; PHOSPHOLIPID VESICLE; PLASMID; PROTEIN MODIFICATION; RECOMBINANT DNA TECHNOLOGY; REVIEW;

APOLIPOPROTEIN A-I; ARTERIOSCLEROSIS; CHOLESTEROL; CYCLODEXTRINS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; PHOSPHOLIPIDS;

EID: 0033941585     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357001774606     Document Type: Review

References (254)

1. Abdou, S., Collomb, J., Sallas, F., Marsura, A., Finance, C. (1997) Beta cyclodextrin derivatives as carriers to enhance the antiviral activity of an antisense oligonucleotide directed toward a coronavirus intergenic consensus sequence. Arch. Virol. 142: 1585-1602
2. Adams, C. W. M., Abdulla, Y. H., Bayliss, O. B., Morgan, R. S. (1967) Modification of aortic atheroma and fatty liver in cholesterol-fed rabbits by intravenous injection of saturated and polyunsaturated lecithins. J. Pathol. Bacteriol. 94: 77-87
3. Ameli, S., Hultgardh-Nilsson, A., Cercek, B., Shah, P. K., Forrester, J. S., Ageland, H., Nilsson, J. (1994) Recombinant apolipoprotein A-I Milano reduces intimai thickening after balloon injury in hypercholesterolemic rabbits. Circulation 90: 1935-1941
4. Andersen, G. H., Robbins, F. M., Domingues, F. J. (1983) The utilisation of Schardinger dextrins by the rat. Toxicol. Appl. Pharmacol. 5: 257-266
5. Andersson, L.-O. (1996) Pharmacology of apolipoprotein A-I. Curr. Opin. Lipidol. 8: 225-228
6. Antenucci, R. N., Palmer, J. K. (1984) Enzymatic degradation of alpha and beta-cyclodextrins by bacteroides of human colon. J. Agric. Food Chem. 32: 1316-1321
7. Antlsperger, G. (1992) Uses for cyclodextrins.In: Hedges, A. R. (ed.) Mins. 6th Int. Symp. Cyclodextrins. Editions de Sante, Paris, pp 277-283
8. Asztalos, B., Roheim, P. S. (1995) Presence and formation of 'free apolipoprotein A-I-like' particles in human plasma. Arterioscler. Thromb. Vasc. Biol. 15: 1419-1423
9. Asztalos, B., Zhang, W., Roheim, P. S., Wong, L. (1997) Role of free apolipoprotein A-I in cholesterol efflux. Formation of pre-alpha-migrating high-density lipoprotein particles. Arterioscler. Thromb. Vasc. Biol. 17: 1630-1636
10. Atger, V. M., de la Liera Moya, M., Stoudt, G. W., Rodrigueza, W. V., Phillips, M. C., Rothblat, G. H. (1997) Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells. J. Clin. Invest. 99: 773-780
11. Awad, A. B., Chen, Y. C., Fink, C. S., Hennessey, T. (1996) B-Sitosterol inhibits HT-29 human colon cancer cell growth and alters membrane lipids. Anticancer Res. 16: 2797-2804
12. Badimon, J. J., Badimon, L., Galvez, A., Dische, R., Fuster, V. (1989) High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. Lab. Invest. 60: 455-461
13. Badimon, J. J., Badimon, L., Fuster, V. (1990) Regression of atherosclerotic lesions by high density lipoprotein fraction in the cholesterol-fed rabbit. J. Clin. Invest. 85: 1234-1241
14. Banka, C. L., Black, A. S., Curtiss, L. K. (1994) Localization of an apolipoprotein A-I epitope critical for lipoprotein-mediated cholesterol efflux from monocytic cells. J. Biol. Chem. 269: 10288-10297
15. Barbaras, R., Puchois, P., Fruchart, J.-C., Ailhaud, G. (1987) Cholesterol efflux from cultured adipose cells is mediated by LpA-I particles but not LpA-I : LpA-II particles. Biochem. Biophys. Res. Commun. 142: 63-69
16. Bartholow, L. C., Geyer, R. P. (1982) Sterol efflux from mammalian cells induced by human serum albumin-phospholipid complexes: dependence on phospholipid acyl chain length, degree of saturation, and net charge. J. Biol. Chem. 257: 3126-3130
17. Bergeron, J., Frank, P. G., Scales, D., Meng, Q.-H., Castro, G., Marcel, Y. L. (1995) Apolipoprotein A-I conformation in reconstituted discoidal lipoproteins varying in phospholipid and cholesterol content. J. Biol. Chem. 270: 27429-27438
18. Bergeron, J., Frank, P. G., Emmanuel, F., Latta, M., Zhao, Y., Sparks, D. L., Rassart, E., Denefle, P., Marcel, Y. L. (1997) Characterization of human apolipoprotein A-I expressed in Escherichia coli. Biochim. Biophys. Acta 1344: 139-152
19. Bielicki, J. K., Johnson, W. J., Weinberg, R. B., Glick, J. M., Rothblat, G. H. (1992) Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol. J. Lipid Res. 33: 1699-1709
20. Bielicki, J. K., McCall, M. R., Forte, T. M. (1999) Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage-like foam cells. J. Lipid Res. 40: 85-92
21. Bisgaier, C. L., Siebenkas, M. V., Williams, K. J. (1989) Effects of apolipoproteins A-IV and A-I on the uptake of phospholipid liposomes by hepatocytes. J. Biol. Chem. 264: 862-869
22. Bittman, R. (1988)In: Yeagle, P. L (ed.) Biology of Cholesterol. CRC, Boca Raton, Florida, pp 173-195
23. Boggs, J. M. (1987) Lipid intermolecular hydrogen bonding: influence on structural organization and membrane function. Biochim. Biophy. Acta 906: 353-404
24. Bolyan, D., Ganzler, K. (1998) Chiral separation of antisense oligonucleotides: a feasibility study. Biomed. Chromatogr. 12: 179-180
25. Braschi, S., Neville, T. A.-M., Vohl, M.-C., Sparks, D. L. (1999) Apolipoprotein A-I charge and conformation regulate the clearance of reconstituted high density lipoprotein in vivo. J. Lipid Res. 40: 522-532
26. Brasseur, R., de Meutter, J., Vanloo, B., Goormaghtigh, E., Ruysschaert, J. M., Rosseneu, M. (1990) Mode of assembly of amphipathic helical segments in model high-density lipoproteins. Biochim. Biophys. Acta 1043: 245-252
27. Bressolle, F., Audran, M., Pham, T. N., Vallon, J. J. (1996) Cyclodextrins and enantiomeric separations of drugs by liquid chromatography and capillary electrophoresis: basic principles and new developments. J. Chromatogr. B. Biomed. Appl. 687: 303-336
28. Brewster, M. E., Estes, K. S., Loftsson, T., Perchalski, R., Derendorf, H., Mullersman, G., Bodor, N. (1988) Inproved delivery through biological membranes. XXXL. Solubilization and stabilization of an estradiol chemical delivery system by modified β-cyclodextrins. J. Pharm. Sci. 77: 981-985
29. Brewster, M. E., Estes, K. S., Bodor, N. (1989) Development of non-surfactant formulation for alfaxalone through the use of chemically-modified cyclodextrine. J. Parenter Sci. Technol. 43: 262-265
30. Brewster, M. E., Anderson, W. R., Estes, K. S., Bodor, N. (1991) Development of aqueous patenteral formulations for carbamazepine through the use of modified cyclodextrins. J. Pharm. Sci. 80: 380-383
31. Brewster, M. E., Anderson, W. R., Meinsma, D., Moreno, D., Webb, A. I., Pablo, L., Estes, K. S., Derendorf, H., Bodor, N., Sawchuk, R., Cheung, B., Pop, E. (1997) Intravenous and oral pharmacokinetic evaluation of a z-hydroxypropyl-beta-cyclodextrin-based formulation of carbamazepine in the dog: comparison with commerically available tablets and suspensions. J. Pharm. Sci. 86: 335-339
32. Brouillette, C. G., Anantharamaiah, G. M. (1995) Structural models of human apolipoprotein A-I. Biochim. Biophys. Acta 1256: 103-129
33. Brown, M. S., Goldstein, J. L. (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34-47
34. Brown, A. J., Jessup, W. (1999) Oxysterols and atherosclerosis. Atherosclerosis 142: 1-28
35. Brown, D. A., London, E. (1998) Structure and origin of ordered lipid domains in biological membranes. J. Membr. Biol. 164: 103-114
36. Brown, M. S., Ho, Y. K., Goldstein, J. L. (1980) The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters. J. Biol. Chem. 255: 9344-9352
37. Brown, A. J., Leong, S. L., Dean, R. T., Jessup, W. (1997) 7-Hydroperoxycholesterol and its products in oxidized low density lipoprotein and human atherosclerotic plaque. J. Lipid Res. 38: 1730-1745
38. Bruckdorfer, K. R., Sherry, M. K. (1984) The solubility of cholesterol and its exchange between membranes. Biochim. Biophys. Acta 769: 187-196
39. Burns, C. H., Rothblat, G. H. (1969) Cholesterol excretion by tissue culture cells: effect of serum lipids. Biochim. Biophys. Acta 176: 616-625
40. Carpenter, T. O., Gerloczy, A., Pitha, J. (1995) Safety of parenteral hydroxylpropyl β-cyclodextrin. J. Pharm. Sci. 84: 222-225
41. Castle, C. K., Pape, M. E., Marotti, K. R., Melchior, G. W. (1991) Secretion of pre-beta-migrating apoA-I by cynomolgus monkey hepatocytes in culture. J. Lipid Res. 32: 439-447
42. Castro, G. R., Fielding, C. J. (1988) Early incorporation of cell-derived cholesterol into pre-β-migrating high-density lipoprotein. Biochemistry 27: 25-29
43. Chen, C., Applegate, K., King, W. C., Glomset, J. A., Norum, K. R., Gjone, E. (1984) A study of the small spherical high density lipoproteins of patients afflicted with familial lecithin : cholesterol acyltransferase deficiency. J. Lipid Res. 25: 269-282
44. Clay, M. A., Newnham, H. H., Forte, T. M., Barter, P. J. (1992) Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apoA-1 from HDL and subsequent formation of discoidal HDL. Biochim. Biophys. Acta 1124: 52-58
45. Clejan, S., Bittman, R. (1984) Kinetics of cholesterol and phospholipid exchange between Mycoplasma gallisepticum cells and lipid vesicles. J. Biol. Chem. 259: 441-448
46. Croyle, M. A., Roessler, B. J., Amidon, G. L. (1997) Beta cyclodextrins enhance gene delivery to the intestine. Proc. 24th Intl Symp. Contr. Release Bioact. Mater., Stockholm, 675-676
47. Croyle, M. A., Roessler, B. J., Hsu, C.-P., Sun, R., Amidon, G. L. (1998) Beta cyclodextrins enhance adenoviral-mediated gene delivery to the intestine. Pharm. Res. 15: 1348-1355
48. Cserhati, T., Forgacs, E., Szejtli, J. (1996) Inclusion complex formation of antisense nucleotides with hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 141: 1-7
49. Cyclolab (1995) Product Catalogue on Cyclodextrins. Budapest, Hungary
50. Cyclolab (1999) Cyclodextrin News, 13. http://hungary.com/ cyclolab/cd_news (accessed)
51. Czarnecka, H., Yokoyama, S. (1995) Lecithin : cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux. Biochemistry 34: 4385-4392
52. Daerr, W. H., Greten, H. (1982) In vitro modulation of the distribution of normal human plasma high-density lipoprotein subfractions through the lecithin : cholesterol acyltransferase reaction. Biochim. Biophys. Acta 710: 128-133
53. Dass, C. R. (1998) Targeted Delivery of DNA for Cancer Therapy. PhD thesis, Charles Sturt University
54. Dass, C. R., Burton, M. A. (1999) Lipoplexes and tumours. J. Pharm. Pharmacol. 51: 755-770
55. Dass, C. R., Walker, T. L., DeCruz, E. E., Burton, M. A. (1996) In vitro evaluation of ion-exchange microspheres as carriers of plasmid DNA. Pharm. Sci. 2: 401-405
56. Dass, C. R., DeCruz, E. E., Walker, T. L., Burton, M. A. (1997a) Tumor gene targeting using microspheres: cell culture and in vivo studies. Drug Delivery 4: 263-267
57. Dass, C. R., Walker, T. L., DeCruz, E. E., Burton, M. A. (1997b) Enhanced anticancer therapy mediated by specialized liposomes. J. Pharm. Pharmacol. 49: 972-975
58. Dass, C. R., Walker, T. L., DeCruz, E. E., Burton, M. A. (1997c) Cationic liposomes and gene therapy for solid tumours. Drug Delivery 4: 151-165
59. Dass, C.R., DeCruz, E. E., Walker, T. L., Burton, M. A. (1997d) Barriers to liposomal gene transfer into solid tumours. Australas. Biotech. 7: 155-159
60. Dass, C. R., Gelissen, I. C., Kritharides, L., Brown, A. J., Dean, R. T., Jessup, W. (1999a) 7-Ketocholesterol inhibits apoA-I-mediated cholesterol and phospholipid efflux from human foam cells. BCCH (Australasian Cardiovascular Research) 2nd Symposium Proceedings, August, Sydney
61. Dass, C. R., Walker, T. L., Kalle, W. H. J., Burton, M. A. (1999b) A microsphere-lipoplex (microplex) vector for targeted gene therapy of cancer. I. Construction and in vitro evaluation. Drug Delivery 6: 259-270
62. Dass, C. R., Walker, T. L., Kalle, W. H. J., Burton, M. A. (2000) A microsphere-lipoplex (microplex) vector for targeted gene therapy of cancer. II. In vivo biodistribution study in a solid tumour model. Drug Delivery 7: 15-20
63. Davidson, W. S., Lund-Katz, S., Johnson, W. J., Anantharamaiah, G. M., Palgunachari, M. N., Segrest, J. P., Rothblat, G. H., Phillips, M. C. (1994) The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein. J. Biol. Chem. 269: 22975-22982
64. Davidson, W. S., Gillotte, K. L., Lund-Katz, S., Johnson, W. J., Rothblat, G. H., Phillips, M. C. (1995a) The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol. J. Biol. Chem. 270: 5882-5890
65. Davidson, W. S., Rodrigueza, W. V., Lund-Katz, S., Johnson, W. J., Rothblat, G. H., Phillips, M. C. (1995b) Effects of particle size on the efflux of cellular free cholesterol. J. Biol. Chem. 270: 17106-17113
66. Dewailly, P., Decoopman, E., Desreumaux, C., Fruchart, J. C. (1976) Plasma removal of intravenous essential phospholipids in man. In: Peters, H. (ed.) Phosphatidylcholine. Springer Verlag, Berlin, pp 80-86
67. Duchene, D. (ed.) (1987) Cyclodextrins and their Industrial Use. Editions de Sante, Paris, France
68. Favier, M.-L., Remesy, C., Moundras, C., Demigne, C. (1995) Effect of cyclodextrin on plasma lipids and cholesterol metabolism in the rat. Metabolism 44: 200-206
69. Ferezou, J., Riottot, M., Serougne, C., Cohen-Solal, C., Catala, I., Alquier, C., Parquet, M., Juste, C., Lafont, H., Mathe, D., Corring, T., Lutton, C. (1997) Hypocholesterolemic action of β-cyclodextrin and its effects on cholesterol metabolism in pigs fed a cholesterol-enriched diet. J. Lipid Res. 38: 86-100
70. Fielding, P. E., Fielding, C. J. (1980) Evidence for a cholesteryl ester transfer complex in human plasma. Proc. Natl Acad. Sci. USA 77: 3327-3330
71. Fielding, C. J., Fielding, P. E. (1981) Regulation of human plasma lecithin:cholesterol acyltransferase activity by lipoprotein acceptor cholesteryl ester content. J. Biol. Chem. 256: 2102-2104
72. Fielding, C. J., Fielding, P. E. (1995a) Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36: 211-228
73. Fielding, P. E., Fielding, C. J. (1995b) Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochemistry 34: 14288-14292
74. Flourie, B., Molis, C., Achour, L. (1993) Fate of β-cyclodextrin in the human intestine. J. Nutr. 123: 676-680
75. Forte, T. M., Goth-Goldstein, R., Nordhausen, R. W., McCall, M. R. (1993) Apolipoprotein A-I cell membrane interaction: extracellular assembly of heterogeneous nascent HDL particles. J. Lipid Res. 34: 317-324
76. Forte, T. M., Bielicki, J. K., Goth-Goldstein, R., Selmek, J., McCall, M. R. (1995) Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT. J. Lipid Res. 36: 148-157
77. Forte, T. M., Bielicki, J. K., Knoff, L., McCall, M. R. (1996) Structural relationships between nascent apoA-I-containing particles that are extracellularly assembled in cell culture. J. Lipid Res. 37: 1706-1085
78. Fournier, N., de la Llera Moya, M., Burkey, B. F., Swaney, J. B., Paterniti, J., Moatti, N., Atger, V., Rothblat, G. H. (1996) Role of HDL phospholipid in efflux of cell cholesterol to whole serum: Studies with human apoA-1 transgenic rats. J. Lipid Res. 37: 1704-1711
79. Francone, O. L., Gurakar, A., Fielding, C. (1989) Distribution and functions of lecithin : cholesterol acyltransferase and cholesterol transfer protein in plasma lipoproteins. J. Biol. Chem. 264: 7066-7072
80. Frank, P. G., Bergeron, J., Emmanuel, F., Lavigne, J.-P., Sparks, D. L., Denefle, P., Rassart, E., Marcel, Y. L. (1997) Deletion of central α-helices in human apolipoprotein A-I: effect on phospholipid association. Biochemistry 36: 1798-1806
81. Friedman, M., Byers, S. O., Rosenman, R. H. (1957) Resolution of aortic atherosclerotic infiltration in the rabbit by phosphatide infusion. Proc. Soc. Exp. Biol. Med. 95: 586-588
82. Frijlink, H. W., Eissens, A. C., Hefting, N. R., Poelstra, K., Lerk, C. F., Meijer, D. K. F. (1991) The effect of parenterally administered cyclodextrins on cholesterol levels in the rat. Pharm. Res. 8: 9-16
83. Fugler, L., Clejan, S., Bittman, R. (1985) Movement of cholesterol between vesicles prepared with different phospholipids or sizes. J. Biol. Chem. 260: 4098-4102
84. Gelissen, I. C., Brown, A. J., Mander, E. L., Kritharides, L., Dean, R. T., Jessup, W. (1996) Sterol efflux is impaired from macrophage foam cells selectively enriched with 7-ketocholesterol. J. Biol. Chem. 271: 17852-17860
85. Gelissen, I. C., Kritharides, L., Dean, R. T., Jessup, W., Brown, A. J. (1999) Efflux of cholesterol and 7-ketocholesterol from macrophages: essential role of phospholipids. J. Lipid Res. 40: 1636-1646
86. Gerbhardt, D. O. E., Schicht, I. M., Paul, L. C. (1984) The immunochemical determination of apolipoprotein A-I and "free" apolipoprotein A-I in serum of patients on chronic haemodialysis. Ann. Clin. Biochem. 21: 301-305
87. Ghiselli, G., Rhode, M. F., Tanebaum, S., Krishnan, S., Gotto, A. M. (1985) Origin of apolipoprotein A-I polymorphism in plasma. J. Biol. Chem. 260: 15662-15668
88. Gillotte, K. L., Davidson, W. S., Lund-Katz, S., Rothblat, G. H., Phillips, M. C. (1996) Apolipoprotein A-I structural modification and the functionality of reconstituted high density lipoprotein particles in cellular cholesterol efflux. J. Biol. Chem. 271: 23792-23798
89. Gillotte, K. L., Davidson, W. S., Lund-Katz, S., Rothblat, G. H., Phillips, M. C. (1998) Removal of cellular cholesterol by pre-β-HDL involves plasma membrane microsolubilization. J. Lipid Res. 39: 1918-1928
90. Girao, H., Mota, M. C., Ramalho, J., Pereira, P. (1998) Cholesterol oxides accumulate in human cataracts. Exp. Eye Res. 66: 645-652
91. Glass, C. K., Pittman, R. C., Keller, G. A., Steinberg, D. (1983) Tissue sites of degradation of apoprotein A-I in the rat. J. Biol. Chem. 258: 7161-7167
92. Glomset, J. A. (1968) The plasma lecithin:cholesterol acyltransferase reaction. J. Lipid Res. 9: 155-167
93. Goldberg, D. I., Beltz, W. F., Pittman, R. C. (1991) Evaluation of pathways for the cellular uptake of high density lipoprotein cholesterol esters in rabbits. J. Clin. Invest. 87: 331-346
94. Goldstein, J. L., Brown, M. S. (1974) Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J. Biol. Chem. 249: 5153-5162
95. Gordon, J. I., Sims, H. F., Lentz, S. R., Edelstein, C., Scanu, A. M., Strauss, A. W. (1983) Proteolytic cleavage of human preproapolipoprotein A-I. J. Biol. Chem. 258: 4037-4044
96. Guo, L. S. S., Hamilton, R. L., Goerke, J., Weinstein, J. N., Havel, R. J. (1980) Interaction of unilamellar liposomes with serum lipoproteins and apolipoproteins. J. Lipid Res. 21: 993-1000
97. Guyton, J. R., Black, B. L., Seidel, C. L. (1990) Focal toxicity of oxysterols in vascular smooth muscle cell culture: a model of the atherosclerotic core region. Am. J. Pathol. 137: 425-434
98. Habus, I., Zhao, Q., Agarval, S. (1995) Hybridization properties, nuclease stability, and cellular uptake of the oligonucleotide-amino-β-cyclodextrins and adamantane conjugates. Bioconjug. Chem. 6: 327-331
99. Hara, H., Yokoyama, S. (1991) Interaction of free apolipoproteins with macrophages. J. Biol. Chem. 266: 3080-3086
100. Hara, H., Yokoyama, S. (1992) Role of apolipoproteins in cholesterol efflux from macrophages to lipid microemulsion: Proposal of a putative model for the pre-β high density lipoprotein pathway. Biochemistry 31: 2040-2046
101. Heideman, C. L., Hoff, H. F. (1982) Lipoproteins containing apolipoprotein A-I extracted from human aortas. Biochim. Biophys. Acta 711: 431-444
102. Ho, Y. K., Brown, M. S., Goldstein, J. L. (1980) Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: stimulation by high density lipoproteins and other agents. J. Lipid Res. 21: 391-398
103. Horowitz, B. S., Goldberg, I. J., Merab, J., Vannit, T., Ramakrishnan, R., Ginsberg, H. N. (1992) Role of the kidney in increased clearance of apoliprotein A-I in subjects with reduced high density lipoprotein cholesterol concentrations. In: Miller, N. E., Tall, A. R. (eds) High Density Lipoproteins and Atherosclerosis III. Excerpta Medica, Amsterdam, pp 215-222
104. Huang, Y., von Eckardstein, A., Assmann, G. (1993) Cell-derived unesterified cholesterol cycles between different HDLs and LDL for its effective esterification in plasma. Arterioscler. Thromb. 13: 445-458
105. Huang, Y., von Eckardstein, A., Wu, S., Maeda, N., Assmann, G. (1994) A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells. Proc. Natl Acad. Sci. USA 91: 1834-1838
106. Irie, T., Uekama, K. (1997) Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J. Pharm. Sci. 86: 147-162
107. Irie, T., Uekama, K. (1999) Cyclodextrins in peptide and protein delivery. Adv. Drug Del. Rev. 36: 101-123
108. Irie, T., Fukunaga, K., Garwood, M. K., Carpenter, T. O., Pitha, J., Pitha, J. (1992) Hydroxypropylcyclodextrins in parenteral use. II. Effects on transport and disposition of lipids in rabbit and humans. J. Pharm. Sci. 81: 524-528
109. Ishida, B. Y., Frolich, J., Fielding, C. J. (1987) Prebeta-migrating high density lipoprotein: quantitation in normal and hyperlipidaemic plasma by solid phase radioimmunoassay following electrophoretic transfer. J. Lipid Res. 28: 778-786
110. Ishida, B. Y., Albee, D., Paigen, B. (1990) Interconversion of prebeta-migrating lipoproteins containing apolipoprotein A-I and HDL. J. Lipid Res. 31: 227-236
111. Janini, G. M., Muschik, G. M., Issaq, H. J. (1996) Electrokinetic chromatography in suppressed electroosmotic flow environment: Use of a charged cyclodextrin for the separation of enantiomers and geometric isomers. Electrophoresis 17: 1575-1583
112. Jauhiainen, M., Metso, J., Pahlman, R., Blomqvist, S., van Tol, A., Ehnholm, C. (1993) Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J. Biol. Chem. 268: 4032-4036
113. Jessup, W., Brown, A. J., Dass, C. R., Gelissen, I. C., Dean, R. T., Kritharides, L. (1999) Sterol export from macrophage foam cells. Aust. Vasc. Biol. Soc. Confer., Adelaide, (abstract)
114. Jian, B., de la Llera-Moya, M., Royer, L., Rothblat, G., Francone, O., Swaney, J. B. (1997) Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid. J. Lipid Res. 38: 734-744
115. Johnson, W. J., Mahlberg, F. H., Chacko, G. K., Phillips, M. C., Rothblat, G. H. (1988) The influence of cellular and lipoprotein cholesterol contents on the flux of cholesterol between fibroblasts and high density lipoproteins. J. Biol. Chem. 263: 14099-14106
116. Johnson, W. J., Mahlberg, F. H., Rothblat, G. H., Phillips, M. C. (1991) Cholesterol transport between cells and high density lipoproteins. Biochim. Biophys. Acta 1085: 273-298
117. Jonas, A., Kezdy, K., Williams, M. I., Rye, K.-A. (1988) Lipid transfers between reconstituted high density lipoprotein complexes and low density lipoproteins: effects of plasma protein factors. J. Lipid Res. 29: 1349-1357
118. Jonas, A., Kezdy, K. E., Wald, J. H. (1989) Defined apolipoprotein A-I conformations in reconstituted high density lipoprotein discs. J. Biol. Chem. 264: 4818-4824
119. Jonas, A., Steinmetz, A., Churgay, L. (1993) The number of amphipathic α-helical segments of apolipoproteins A-I, E, and A-IV determines the size and functional properties of their reconstituted lipoprotein particles. J. Biol. Chem. 268: 1596-1602
120. Karlin, J. B., Johnson, W. J., Benedict, C. R., Chacko, G. J., Phillips, M. C., Rothblat, G. H. (1987) Cholesterol flux between cells and high density lipoprotein: lack of relationship to specific binding of the lipoprotein to the cell surface. J. Biol. Chem. 262: 12557-12564
121. Kilsdank, E. P., Morel, D. W., Johnson, W. J., Rothblat, G. H. (1995) Inhibition of cellular cholesterol efflux by 25-hydroxycholesterol. J. Lipid Res. 36: 505-516
122. Klein, U., Gimpl, G., Farenholz, F. (1995) Alteration of the myometrial plasma membrane cholesterol content with β-cyclodextrin modulates the binding affinity of the oxytocin receptor. Biochemistry 34: 13784-13793
123. Knoche, B., Gehrcke, B., Konig, W. A., Wainer, I. W. (1996) Determination of the enantiomeric composition of mexiletine and its four hydroxylated metabolites in urine by enantioselective capillary gas chromatography. Chirality 8: 30-34
124. Koizumi, J., Kano, M., Okabayashi, K., Jadhav, A., Thompson, G. R. (1988) Behavior of human apolipoprotein A-1 : phospholipid and apoHDL : phospholipid complexes in vitro and after injection into rabbits. J. Lipid Res. 29: 1405-1415
125. Koppaka, V., Silvestro, L., Engler, J. A., Brouillette, C. G., Axelsen, P. H. (1999) The srtucture of human lipoprotein A-I. J. Biol. Chem. 274: 14541-14544
126. Kreuzer, J., Lloyd, M. B., Bok, D., Fless, G. M., Scanu, A. M., Lusis, A. J., Haberland, M. E. (1994) Lipoprotein(a) displays increased accumulation compared with low-density lipoprotein in the murine arterial wall. Chem. Phys. Lipids 67/68: 175-190
127. Kritharides, L., Jessup, W., Mander, E., Dean, R. T. (1995) Apolipoprotein A-I-mediated efflux of sterols from oxidised LDL-loaded macrophages. Arterioscler. Thromb. Vasc. Biol. 15: 276-289
128. Kritharides, L., Kus, M., Brown, A. J., Jessup, W., Dean, R. T. (1996) Hydroxypropyl-β-cyclodextrin-mediated efflux of 7-ketocholesterol from macrophage foam cells. J. Biol. Chem. 271: 27450-27455
129. Kruth, H. S. (1997) The fate of lipoprotein cholesterol entering the arterial wall. Curr. Opin. Lipidol. 8: 246-252
130. Kruth, H. S., Skarlatos, S. L., Gaynor, P. M., Gamble, W. (1994) Production of cholesterol-enriched high density lipoproteins by human monocyte-derived macropahges is a mechanism that contributes to macrophage cholesterol efflux. J. Biol. Chem. 269: 24511-24518
131. Kuivenhoven, J. A., Stalenhoef, A. F., Hill, J. S., Dernacker, P. N., Errami, A., Kastelein, J. J., Pritchard, P. H., (1996) Two novel molecular defects in the LCAT gene are associated with fish eye disease. Arterioscler. Thromb. Vasc. Biol. 16: 294-303
132. Kunitake, S. T., Mendel, C. M., Hennessy, L. K. (1992) Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic properties. J. Lipid Res. 33: 1807-1816
133. Laccotripe, M., Makrides, S. C., Jonas, A., Zannis, V. I. (1997) The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein. J. Biol. Chem. 272: 17511-17522
134. Lefevre, M., Sloop, C. H., Roheim, P. S. (1988) Characterization of dog prenodal peripheral lymph lipoproteins. Evidence for the peripheral formation of lipoprotein-unassociated apoA-I with slow pre-β electrophoretic mobility. J. Lipid Res. 29: 1139-1148
135. Levrat, M.-A., Favier, M.-L., Moundras, C. (1994) Role of propionic acid and bile acids excretion in the hypocholesterolemic effects of oligosaccharides. J. Nutr. 124: 531-538
136. Li, Q., Czarnecka, H., Yokoyama, S. (1995) Involvement of a cellular surface factor(s) in lipid-free apolipoprotein-mediated cellular cholesterol efflux. Biochim. Biophys. Acta 1259: 227-234
137. Li, Q., Tsujita, M., Yokoyama, S. (1997) Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages. Biochemistry 36: 12045-12052
138. Li, D., Weng, S., Yang, B., Zander, D. S., Saldeen, T., Nichols, W. W., Khan, S., Mehta, J. L. (1999) Inhibition of arterial thrombus formation by apoAl Milano. Arterioscler. Thromb. Vasc. Biol. 19: 378-383
139. Liang, H.-Q., Rye, K.-A., Barter, P. J. (1995) Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools. Biochim. Biophys. Acta 1257: 31-37
140. Libby, P., Clinton, S. K. (1993) The role of macrophages in atherogenesis. Curr, Opin. Lipidol. 4: 355-363
141. Mahlberg, F. H., Rothblat, G. H. (1992) Cellular cholesterol efflux: Role of cell membrane kinetic pools and interaction with apolipoproteins A-I, A-II and Cs. J. Biol. Chem. 267: 4541-4550
142. Mahlberg, F. H., Glick, J. M., Lund-Katz, S., Rothblat, G. H. (1991) Influence of apolipoproteins A-I, A-II and C on the metabolism of membrane and lysosomal cholesterol in macrophages. J. Biol. Chem. 266: 19930-19937
143. Malmendier, C. L., Delcroix, C., Ameryckx, J. P. (1983) In vivo metabolism of human apoprotein A-1-phospholipid complexes. Comparison with human high density lipoprotein-apoprotein A-1 metabolism. Clin. Chim. Acta 131: 201-210
144. Marcel, Y. L., Jewer, D., Leblond, L., Weech, P. K., Milne, R. W. (1989) Lipid peroxidation changes the expression of specific epitopes of apolipoprotein A-I. J. Biol. Chem. 264: 19942-19950
145. Marttin, E., Verhoef, J. C., Merkus, F. W. (1998) Efficacy, safety and mechanism of action of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs. J. Drug Target. 6: 17-36
146. Mattsson-Hulten, L., Lindmark, H., Diczfalusy, U., Bjorkhem, I., Ottosson, M., Liu, Y., Bondjers, G., Wiklund, O. (1996) Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages. J. Clin. Invest. 97: 461-468
147. McCall, M. R., Forte, T. M., Shore, V. G. (1988) Heterogeneity of nascent high density lipoproteins secreted by the hepatoma-derived cell line, HepG2. J. Lipid Res. 29: 1127-1137
148. McCall, M. R., Tang, J. Y., Bielicki, J. K., Forte, T. M. (1995) Inhibition of lecithin:cholesterol acyltransferase and modification of HDL-apolipoproteins by aldehydes. Arterioscler. Thromb. Vasc. Biol. 15: 1599-1606
149. McLean, L. R., Phillips, M. C. (1984) Cholesterol transfer from small and large unilamellar vesicles. Biochim. Biophys. Acta 776: 21-26
150. Mendez, A. J. (1997) Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion. J. Lipid Res. 38: 1807-1821
151. Mendez, A. J., Uint, L. (1996) Apolipoprotein-mediated cellular cholesterol and phospholipid efflux depend on a functional Golgi apparatus. J. Lipid Res. 37: 2510-2524
152. Mendez, A. J., Anantharamaiah, G. M., Segrest, J. P., Oram, J. F. (1994) Synthetic amphipathic helical peptides that mimic apolipoprotein A-1 in clearing cellular cholesterol. J. Clin. Invest. 94: 1698-1705
153. Miyazawa, I., Ueda, H., Nagase, H., Endo, T., Kobayashi, S., Nagai, T. (1995) Eur. J. Pharm. Sci. 3: 153-162
154. Moundras, C., Behr, S. R., Demigne, C., Mazur, A., Remesy, C. (1994) Fermentable polysaccharides that enhance fecal bile acid excretion lower plasma cholesterol and apolipoprotein E-rich HDL in rats. J. Nutr. 124: 2179-2188
155. Muller, B. W., Albers, E. (1991) Effect of hydrotropic substances on the complexation of sparingly soluble drugs with cyclodextrin derivatives and the influence of cyclodextrin complexation on the pharmacokinetics of the drugs. J. Pharm. Sci. 80: 599-604
156. Musliner, T. A., Long, M. D., Forte, T. M., Nichols, A. V., Gong, E. L., Blanche, P. J., Krauss, R. M. (1991) Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I. J. Lipid Res. 32: 917-933
157. Nanjee, M. N., Crouse, J. R., King, J. M., Hovorka, R., Rees, S. E., Carson, E. R., Morgenthaler, J.-J., Lerch, P., Miller, N. E. (1996a) Effects of intravenous infusion of lipid-free apo A-I in humans. Arterioscler. Thromb. Vasc. Biol. 16: 1203-1214
158. Nanjee, M. N., Miller, N. E. (1996b) Effects of intravenous apolipoprotein A-I/phosphatidylcholine (apo AI/PC) discs in humans. Circulation 94: 2707
159. Neary, R. H., Gowland, E. (1987) Stability of free apolipoprotein A-I concentration in serum, and its measurement in normal and hyperlipidemic subjects. Clin. Chem. 33: 1163-1169
160. Neary, R., Bhatnagar, D., Durrington, P., Ishola, M., Arrol, S., Mackness, M. (1991) An investigation of the role of lecithin:cholesterol acyltransferase and triglyceride-rich lipoproteins in the metabolism of pre-beta high density lipoproteins. Atherosclerosis 89: 35-48
161. Neufeld, E. B., Cooney, A. M., Pitha, J., Dawidowicz, E. A., Dwyer, N. K., Pentchev, P. G., Blanchette, E. J. (1996) Intracellular trafficking of cholesterol monitored with a cyclodextrin. J. Biol. Chem. 271: 21604-21613
162. New, R. R. C. (1994) Preparation of liposomes. In: Liposomes - A Practical Approach. IRL, Oxford, pp 33-104
163. Nichols, V., Gong, E. L., Blanche, P. J., Forte, T. M. (1983) Characterization of discoidal complexes of phosphatidylcholine, apolipoprotein A-I and cholesterol by gradient gel electrophoresis. Biochim. Biophys. Acta 750: 353-364
164. Nielsen, J. H., Olsen, C. E., Jensen, C., Skibsted, L. H. (1996) Cholesterol oxidation in butter and dairy spread during storage. J. Dairy Res. 63: 159-167
165. Nievelstein, P. F. E. M., Fogelman, A. M., Mottino, G., Frank, J. S. (1991) Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein. Arteriscler. Thromb. 11: 1795-1805
166. Nunez, J. F., Swaney, J. B. (1984) Interaction between hepatic microsomal membrane lipids and apolipoprotein A-I. J. Biol. Chem. 259: 9141-9148
167. Ohta, T., Nakamura, R., Ikeda, Y., Shinohara, M., Miyazaki, A., Horiuchi, S., Matsuda, I. (1992) Differential effect of subspecies of lipoprotein containing apolipoprotein A-I on cholesterol efflux from cholesterol-loaded macrophages: functional correlation with lecithin : cholesterol acyltransferase. Biochim. Biophys. Acta 1165: 119-128
168. Ohvo, H., Slotte, J. P. (1996) Cyclodextrin-mediated removal of sterols from monolayers: effects of sterol structure and phospholipids on desorption rate. Biochemistry 35: 8018-8024
169. Olivier, P., Verwaerde, F., Hedges, A. R. (1991) Subchronic toxicity of orally administered beta-cyclodextrin in rats. J. Am. Coll. Toxicol. 10: 407-419
170. Oram, J. F., Yokoyama, S. (1996) Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J. Lipid Res. 37: 2473-2491
171. Oram, J. F., Brinton, E. A., Bierman, E. L. (1983) Regulation of HDL receptor activity in cultured human skin fibroblasts and human arterial smooth muscle cells. J. Clin. Invest. 72: 1611-1621
172. Oram, J. F., Johnson, C. J., Brown, T. A. (1987) Interaction of high density lipoprotein with its receptor on cultured fibroblasts and macrophages: evidence for reversible binding at the cell surface without internalisation. J. Biol. Chem. 262: 2405-2410
173. Palgunachari, M. N., Mishra, V. K., Lund-Katz, S., Phillips, M. C., Adeyeye, S. O., Alluri, S., Anantharamaiah, G. M., Segrest, J. P. (1996) Only the two end helices of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity. Implications for HDL assembly. Arterioscler. Thromb. Vasc. Biol. 16: 328-338
174. Parente, R. A., Lentz, B. E. (1984) Phase behavior of large unilamellar vesicles composed of synthetic phospholipids. Biochemistry 23: 2353-2359
175. Paszty, C., Maeda, N., Verstuyft, J., Rubin, E. M. (1994) Apolipoprotein A-I transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J. Clin. Invest. 94: 899-903
176. Patel, R. P., Diczfalusy, U., Dzeletovic, S., Wilson, M. T., Darley-Usmar, V. M. (1996) Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper. J. Lipid Res. 37: 2361-2371
177. Peluso, M. R., Dixon, J. L. (1997) Use of cyclodextrin to deliver and to modulate apolipoprotein B-100 production in HepG2 cells. Lipids 2: 811-823
178. Phillips, M. C., McLean, L. R., Stoudt, G. W., Rothblat, G. H. (1980) Mechanism of cholesterol efflux from cells. Atherosclerosis 36: 409-422
179. Phillips, M. C., Johnson, W. J., Rothblat, G. H. (1987) Mechanisms and consequences of cellular cholesterol exchange and transfer. Biochim. Biophys. Acta 906: 223-276
180. Phillips, J. C., Wriggers, W., Li, Z., Jonas, A., Schulten, K. (1997) Predicting the structure of apolipoprotein A-I in reconstituted high density lipoprotein disks. Biophys. J. 73: 2337-2346
181. Phillips, J. C., Wriggers, W., Li, Z., Jonas, A. (1998) HDL and apoA-I. http://www.ks.uluc.edu/Research/apoa1/ (accessed December 1998).
182. Ponsin, G., Sparrow, J. T., Gotto, A. M., Pownall, H. J. (1986) In vivo interaction of synthetic acylated apopeptides with high density lipoproteins in rat. J. Clin. Invest. 77: 559-567
183. Pownall, H. J., Massey, J. B., Kusserow, S. K., Gotto, A. M. (1978) Kinetics of lipid-protein interactions: interaction of apolipoprotein A-1 from human plasma high density lipoproteins with phosphatidylcholine. Biochemistry 17: 1183-1188
184. Pownall, H. J., Massey, J. B., Sparrow, J. T., Gotto, A. M. (1987) In: Gotto, A. M. (ed.) Plasma Lipoproteins. Elsevier, Amsterdam, pp 95-127
185. Rapp, J. H., Lespine, A., Hamilton, R. L., Colyvas, N., Chaumeton, A. H., Tweedie-Hardman, J., Kotite, L., Kunitake, S. T., Havel, R. J., Kane, J. P. (1994) Triglyceride-rich lipoproteins isolated by selective-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler. Thromb. 14: 1767-1774
186. Riottot, M., Olivier, P., Huet, A., Caboche, J.-J., Parquet, M., Khallou, J., Lutton, C. (1993) Hypolipidemic effects of β-cyclodextrin in the hamster and in the genetically hypercholesterolemic Rico rat. Lipids 28: 181-188
187. Rodrigueza, W. V., Pritchard, P. H., Hope, M. J. (1993) The influence of size and composition on the cholesterol mobilizing properties of liposomes in vivo. Biochim. Biophys. Acta 1153: 9-19
188. Rodrigueza, W. V., Williams, K. J., Rothblat, G. H., Phillips, M. C. (1997a) Remodeling and shuttling. Mechanisms for the synergistic effects between different acceptor particles in the mobilization of cellular cholesterol. Arterioscler. Thromb. Vasc. Biol. 17: 383-393
189. Rodrigueza, W. V., Mazany, K. D., Essenburg, A. D., Bisgaier, C. L., Williams, K. J. (1997b) Large versus small unilamellar vesicles mediate reverse cholesterol transport in vivo into two distinct hepatic metabolic pools. Implications for the treatment of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17: 2132-2139
190. Rodrigueza, W. V., Klimuk, S. K., Pritchard, P. H., Hope, M. J. (1998) Cholesterol mobilization and regression of atheroma in cholesterol-fed rabbits induced by large unilamellar vesicles. Biochim. Biophys. Acta 1368: 306-320
191. Roerdink, F., Dijkstra, J., Hartman, G., Bolscher, B., Scherphof, G. (1981) The involvement of parenchymal, Kupffer and endothelial liver cells in the hepatic uptake of intravenously injected liposomes. Biochim. Biophys. Acta 677: 79-89
192. Rooney, M., Tamura-Lis, W., Lis, L. J., Yachnin, S., Kucuk, O., Kauffman, J. W. (1986) The influence of oxygenated sterol compounds on dipalmitoylphosphatidylcholine bilayer structure and packing. Chem. Phys. Lipids 41: 81-92
193. Ross, R. (1995) Cell biology of atherosclerosis. Annu. Rev. Physiol. 57: 791-804
194. Rothblat, G. H., Phillips, M. C. (1982) Mechanism of cellular cholesterol efflux from cells. Effects of acceptor structure and composition. J. Biol. Chem. 257: 4775-4782
195. Rothblat, G. H., Mahlberg, F. H., Johnson, W. J., Phillips, M. C. (1992) Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux. J. Lipid Res. 33: 1091-1097
196. Rothblat, G. H., de la Llera-Moya, M., Atger, V., Kellner-Weibel, G., Williams, D. L., Phillips, M. C. (1999) Cell cholesterol efflux: integration of old and new observations provides new insights. J. Lipid Res. 40: 781-796
197. Rubin, E. M., Krauss, R. M., Spangler, E. A., Verstuyft, J. G., Clift, S. M. (1991) Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I. Nature 353: 265-267
198. Saito, H., Miyako, Y., Handa, T., Miyajima, K. (1997) Effect of cholesterol on apolipoprotein A-I binding to lipid bilayers and emulsions. J. Lipid Res. 38: 287-294
199. Salehian, B., Wang, C., Alexander, G., Davidson, T., McDonald, V., Berman, N., Dudley, R. E., Ziel, F., Swerdloff, R. S. (1995) Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate - a clinical research center study. J. Clin. Endocrinol. Metabol. 80: 3567-3575
200. Savion, N., Kotev-Emeth, S. (1993) Role of apolipoproteins A-I, A-II and C-I in cholesterol efflux from endothelial and smooth muscle cells. Eur. Heart J. 14: 930-935
201. Scherphof, G. L., Morselt, H. (1984) On the size-dependent disintegration of small unilamellar phosphatidylcholine vesicles in rat plasma: evidence of complete loss of vesicle structure. Biochem. J. 221: 423-429
202. Schmitz, G., Niemann, R., Brennhausen, B., Krauss, R. M., Assmann, G. (1985) Regulation of high density lipoprotein receptors in cultured macrophages: role of acyl CoA : cholesterol acyltransferase. EMBO J. 4: 2773-2779
203. Schwenke, D. C., Carew, T. E. (1989a) Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions. Arteriosclerosis 9: 895-907
204. Schwenke, D. C., Carew, T. E. (1989b) Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries. Arteriosclerosis 9: 908-918
205. Segrest, J. P., Jones, M. K., de Loof, H., Brouillette, C. G., Venkatachalapathi, Y. V., Anantharamaiah, G. M. (1992) The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J. Lipid Res. 33: 141-166
206. Segrest, J. P., Garber, D. W., Brouillette, C. G., Harvey, S. C., Anantharamaiah, G. M. (1994) The amphipathic alpha helix: a multifunctional structural motif in plasma apolipoproteins. Adv. Prot. Chem. 45: 303-369
207. Semple, S. C., Chonn, A., Cullis, P. R. (1998) Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo. Adv. Drug Del. Rev. 32: 3-17
208. Milano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits. Circ. Res. 76: 405-411
209. Soutar, A. K., Knight, B. L., Myant, N. B. (1982) The characterization of lipoproteins in the high density fraction obtained from patients with familial lecithin : cholesterol acyltransferase deficiency and their interaction with cultured human fibroblasts. J. Lipid Res. 23: 380-390
210. Sparks, D. L., Phillips, M. C., Lund-Katz, S. (1992) Effect of cholesterol on the charge and structure of apolipoprotein A-I in recombinant high-density lipoproteins particles. J. Biol. Chem. 267: 25830-25838
211. Sparks, D. L., Davidson, W. S., Lund-Katz, S., Phillips, M. C. (1993) The conformation of apolipoprotein A-I in discoidal and spherical recombinant high-density lipoproteins particles. J. Biol. Chem. 268: 23250-23257
212. Sparks, D. L., Anantharamaiah, G. M., Segrest, J. P., Phillips, M. C. (1995) Effect of the cholesterol content of reconstituted LpA-I on lecithin : cholesterol acyltransferase activity. J. Biol. Chem. 270: 5151-5157
213. Stein, O., Stein, Y. (1973) The removal of cholesterol from aortic muscle cells in culture and Lundschutz ascites cells by fractions of human high-density lipoprotein. Biochim. Biophys. Acta 326: 232-244
214. Stein, Y., Stein, O. (1979)In: Scanu, A. M., Wissler, R. W., Getz, G. S. (eds) Biochemistry of Atherosclerosis. Marcel Dekker, New York, pp 313-324
215. Stein, Y., Glangeaud, M. C., Fainaru, M., Stein, O. (1975) The removal of cholesterol from aortic muscle cells in culture and Lundschutz ascites cells by fractions of human high-density apolipoprotein. Biochim. Biophys. Acta 380: 106-118
216. Sun, D., Gilboe, D. D. (1994) Effect of of the platelet-activating factor antogonist BN 50739 and its diluents on mitochondrial respiration and membrane lipids during and following cerebral ischemia. J. Neurochem. 62: 1929-1938
217. Suzuki, M., Sato, A. (1985) Nutritional significance of cyclodextrins: indigestability and hypolipidemic effects of cyclodextrin. J. Nutr. Sci. Vitaminol. 31: 209-223
218. Sviridov, D., Pyle, L. E., Fidge, N. (1996a) Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles. Biochemistry 35: 189-196
219. Sviridov, D., Pyle, L. E., Fidge, N. (1996b) Efflux of cellular cholesterol and phospholipid to apolipoprotein A-I mutants. J. Biol. Chem. 271: 33277-33283
220. Swaney, J. B. (1983) Reconstitution of apolipoprotein A-I from human high-density lipoprotein with bovine brain sphingomyelin. J. Biol. Chem. 258: 1254-1259
221. Szedlacsek, S. E., Wasowicz, E., Hulea, S. A., Nishida, H. I., Kummerow, F. A., Nishida, T. (1995) Esterification of oxysterols by human plasma lecithin-cholesterol acyltransferase. J. Biol. Chem. 270: 11812-11819
222. Szejtli, J. (1988) In: Cyclodextrin Technology. Davies, J. E. D. (ed) Kluwer, Dordrecht, The Netherlands, pp 84-86, 163-169
223. Tabas, I., Marathe, S., Keesler, G. A., Beatini, N., Shiratori, Y. (1996) Evidence that the initial up-regulation of phosphatidylcholine biosynthesis in free cholesterol-loaded macrophages is an adaptive response that prevents cholesterolinduced cellular necrosis. J. Biol. Chem. 271: 22773-22782
224. Tall, A. R. (1993) Plasma cholesteryl ester transfer protein. J. Lipid Res. 34: 1255-1274
225. Tall, A. R., Shipley, G. G., Small, D. M. (1976) Conformational and thermodynamic properties of apoA-I of human plasma high density lipoproteins. J. Biol. Chem. 251: 3749-3755
226. Tanaka, F., Suga, M., Nishikawa, H., Muranaka, H., Ando, M. (1997) Effects of pulmonary surfactant on macrophage migration: Suppression of chemokinesis by surfactant phospholipid and enhancement of chemotaxis by surfactant protein. Respiroiogy 2: 119-126
227. Tansey, J. T., Thuren, T. Y., Jerome, W. G., Hantgan, R. R., Grant, K., Waite, M. (1997) Hydrolysis of phosphatidylcholine by hepatic lipase in discoidal and spheroidal recombinant high-density lipoprotein. Biochemistry 36: 12227-12234
228. Til, H. P., Bar, A. (1998) Subchronic (13-week) oral toxicity study of γ-cyclodextrin in dogs. Regul. Toxicol. Pharmacol. 27: 159-165
229. Toyoda, K., Shada, T., Uneyama, C., Takada, K., Takahashi, M. (1997) Carcinogenicity study of beta-cyclodextrin in F344 rats. Food Chem. Toxicol. 35: 331-336
230. van de Bovenkamp, P., Kosmeijer-Schuil, T. G., Katan, M. B. (1988) Quantification of oxysterols in Dutch foods: egg products and mixed diets. Lipids 23: 1079-1085
231. Vine, D. F., Croft, K. D., Beilin, L. J., Mamo, J. C. (1997) Absorption of dietary cholesterol oxidation products and incorporation into rat lymph chylomicrons. Lipids 32: 887-893
232. Voglino, L., McIntosh, T. J., Simon, S. A. (1998) Modulation of the binding of signal peptides to lipid bilayers by dipoles near the hydrocarbon-water interface. Biochemistry 37: 12241-12252
233. von Eckardstein, A. (1996) Cholesterol efflux from macrophages and other cells. Curr. Opin. Lipidol. 7: 308-319
234. von Eckardstein, Funke, H., Walter, M., Altland, K., Benningahaven, A., Assmann, G. (1990) Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are non-randomly distributed throughout the apolipoprotein A-I primary structure. J. Biol. Chem. 265: 8610-8617
235. Waalkens-Berendsen, D. H., Verhagen, F. J. J., Bar, A. (1998) Embryotoxicity and teratogenicity study with γ-cyclodextrin in rats. Regul. Toxicol. Pharmacol. 27: 166-171
236. Wald, J. H., Goormaghtigh, E., de Mauter, J., Ruysschaert, J.-M., Jonas, A. (1990) Investigation of the lipid domains and apolipoprotein A-I orientation in reconstituted high-density lipoproteins by fluorescence and IR methods. J. Biol. Chem. 265: 20044-20050
237. Walker, T. L., Dass, C. R., Burton, M. A., DeCruz, E. E. (1997) The status of antisense oligodeoxynucleotides as therapeutic agents. Int. J. Pharm. Med. 11: 263-268
238. Walker, T. L., DeCruz, E. E., Dass, C. R., Burton, M. A. (1998) A method for intratumoral continuous infusion of antisense oligodeoxynucleotides. J. Pharm. Sci. 87: 387-389
239. Westman, J. Roobol, C., Heymans, C., Carlson, L. A., Wulfert, E. (1993) Efflux of cholesterol from cholesterol loaded macrophages by incubation with synthetic HDL-particles. Scand. J. Lab. Invest. 53: 773-782
240. Westman, J., Roobol, C., Carlson, L. A., Wulfert, E. (1995) In vitro reverse cholesterol transport from THP-1-derived macrophage-like cells with synthetic HDL particles consisting of proapolipoprotein AI and phosphatidylcholine. Scand. J. Clin. Lab. Invest. 55: 23-33
241. Westman, J., Kallin, B., Bjorkhem, I., Nilsson, J., Diczfalusy, U. (1998) Sterol 27-hydroxylase and apoAI/phospholipid-mediated efflux of cholesterol from cholesterol-laden macrophages: evidence for an inverse relation between the two mechanisms. Arterioscler. Thromb. Vasc. Biol. 18: 554-561
242. Williams, K. J., Scanu, A. M. (1986) Uptake of endogenous cholesterol by a synthetic lipoprotein. Biochim. Biophys. Acta 875: 183-194
243. Williams, K. J., Tabas, I. (1995) The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15: 551-561
244. Williams, K. J., Werth, V. P., Wolff, J. A. (1984) Intravenously administered lecithin liposomes: a synthetic antiatherogenic lipid particle. Perspect. Biol. Med. 27: 417-423
245. Winegar, D. A., Salisbury, J. A., Sundseth, S. S., Hawke, R. L. (1996) Effects of cyclosporin on cholesterol 27-hydroxylation and LDL receptor activity in HepG2 cells. J. Lipid Res. 37: 179-191
246. Yancey, P. G., Bielicki, J. K., Johnson, W. J., Lund-Katz, S., Palgunachari, M. N., Anantharamaiah, G. M., Segrest, J. P., Phillips, M. C., Rothblat, G. H. (1995) Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry 34: 7955 -7965
247. Yancey, P. G., Rodrigueza, W. V., Kilsdonk, E. P. C., Stoudt, G. W., Johnson, W. J., Phillips, M. C., Rothblat, G. H. (1996) Cellular cholesterol efflux mediated by cyclodextrins: demonstration of kinetic pools and mechanism of efflux. J. Biol. Chem. 271: 16026-16034
248. Zannis, V. I., Kurnit, D. M., Breslow, J. L. (1982) Hepatic apolipoprotein A-I and apolipoprotein E and intestinal apolipoprotein A-I are synthesized in precursor isoprotein forms by organ cultures of human fetal tissues. J. Biol. Chem. 257: 536-544
249. Zhao, Q., Temsamani, J., Agarwal, S. (1995) Use of cyclodextrin and its derivatives as carriers for oligonucleotide delivery. Antisense Res. Dev. 5: 185-192
250. Zhao, Q., Temsamani, J., Tadarola, P. L., Jiang, Z., Agarwal, S. (1996a) Effect of different chemically modified oligodeoxynucleotides on immune stimulation. Biochem. Pharmacol. 51: 173-182
251. Zhao, Q., Temsamani, J., Tadarola, P. L., Jiang, Z., Agarwal, S. (1996b) Modulation of oligonucleotide-induced immune stimulation by cyclodextrin analogs. Biochem. Pharmacol. 52: 1537-1544
252. Zhao, Y., Sparks, D. L., Marcel, Y. L. (1996c) Effect of apolipoprotein A-I and surface lipid composition of reconstituted discoidal HDL on cholesterol efflux from cultured fibroblasts. Biochemistry 35: 16510-16518
253. Zhao, Y., Sparks, D. L., Marcel, Y. L. (1996d) Specific phospholipid association with apolipoprotein A-I stimulates cholesterol efflux from human fibroblasts. Studies with reconstituted sonicated lipoproteins. J. Biol. Chem. 271: 25145-25151
254. Zorich, N. L., Kezdy, K. E., Jonas, A. (1987) Properties of discoidal complexes of human apolipoprotein A-I with phosphatidylcholines containing various fatty acid chains. Biochim. Biophys. Acta 919: 181-189